On January 29, Shenzhen Tisenc Medical Devices Co., Ltd. underwent an industrial and commercial change. All the original shareholders withdrew, and WONDFO BIOTECH (300482) was newly added, holding 100% of the shares.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta Corp.

Sema4 said Tuesday that it will acquire GeneDx from Opko Health for approximately $623 million in cash, stock consideration, and milestone payments.

A variety of diagnostic companies, including Danaher, PerkinElmer, Cue Health, T2 Biosystems, SomaLogic, and Fluidigm, announced preliminary earnings results for the fourth quarter and full year 2021 on Tuesday.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho

On December 14, Beijing Hotgen Biotech Co., Ltd. announced that the company intends to acquire 38.0993% equity interest in Oriomics by way of equity transfer and subscription of additional registered capital at a price of CNY 153 million.

Since December 2019, the epidemic has raged all over the world. Affected by the epidemic, more than 1,400 China in vitro diagnostic companies are facing severe challenges. As of the end of November, 24 IVD-related companies have been successfully listed during the epidemic.

Danaher said late Wednesday that it has priced its offering of $1 billion principal amount of senior notes.

Agilent Technologies reported after the close of the market on Monday that its fiscal fourth quarter revenues increased 12 percent year over year.

Burning Rock Biotech reported on Tuesday morning that its third quarter revenues rose about 2 percent year over year.